𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of hepatitis B virus markers in several institutions for the mentally handicapped in the autonomous community of Madrid

✍ Scribed by Diana Carrascosa; Ma De La Vega Ramírez; Angela Casado; Ma Roserio Je La Torre; Ma Encarnación Lópezfernández; Julia Sáez


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
440 KB
Volume
7
Category
Article
ISSN
1042-0533

No coin nor oath required. For personal study only.

✦ Synopsis


In order to determine the prevalence of hepatitis B virus (HBV) markers, 400 patients were studied: 134 residents of an institution (RI) for the mentally retarded and 266 under non-residential care (NRC). In the residential institutions, all markers were absent in 69 (65.7%) of 105 patients with Down syndrome and 20 (69.0%) of 29 clients without Down syndrome. In the NRC clients, 167 (85.6%) of 195 patients with Down syndrome and 65 (91.5%) of 71 clients with other mental defects (psychologically and physically handicapped, autism) had negative tests for HBV markers. The prevalence of the hepatitis B surface antigen (HBsAg) was higher in institutionalized mentally retarded (RI) and older patients (21+ years). Examination of 195 Down patients revealed a higher frequency (1.4 times) of surface antigen carriers as strictly matched non-Down syndrome cases (point prevalences 14.2% and 10.3%, respectively). The higher prevalence in affected cases appears to be primarily associated with a longer persistence of antigenemia. Results related to the sex of the patients were less clear. Neither affected nor non-affected patients showed significant differences in prevalence among males and females. o 1995 Wiley-Liss, Inc.


📜 SIMILAR VOLUMES


Prevalence and significance of HBeAg and
✍ Diana Carrascosa; Ma Vega Ramírez; Angela Casado; Ma Rosario De La Torre; Ma Enc 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 1 views

Hepatitis B virus (HBV) surface antigen (HBsAg) and antibody to HBsAg (antiHBs) are excellent markers for HBV infection and its immunity. A total of 414 patients, 312 Down syndrome and 102 non-Down's syndrome, were studied, and 142 were residents of an institution (RI), whereas 272 were in nonreside